A carregar...
Anti‐vascular endothelial growth factor for diabetic macular oedema: a network meta‐analysis
BACKGROUND: Diabetic macular oedema (DMO) is a common complication of diabetic retinopathy. Antiangiogenic therapy with anti‐vascular endothelial growth factor (anti‐VEGF) modalities can reduce oedema and thereby improve vision and prevent further visual loss. These drugs have replaced laser photoco...
Na minha lista:
| Publicado no: | Cochrane Database Syst Rev |
|---|---|
| Main Authors: | , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
John Wiley & Sons, Ltd
2017
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6481463/ https://ncbi.nlm.nih.gov/pubmed/28639415 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/14651858.CD007419.pub5 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|